Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Capital Leases: 2016-2024

Historic Capital Leases for Lifecore Biomedical (LFCR) over the last 4 years, with May 2024 value amounting to $3.2 million.

  • Lifecore Biomedical's Capital Leases rose 0.03% to $3.2 million in Q2 2024 from the same period last year, while for May 2024 it was $3.2 million, marking a year-over-year increase of 0.03%. This contributed to the annual value of $3.2 million for FY2024, which is 0.03% up from last year.
  • As of Q2 2024, Lifecore Biomedical's Capital Leases stood at $3.2 million, which was up 0.03% from $3.2 million recorded in Q2 2023.
  • In the past 5 years, Lifecore Biomedical's Capital Leases registered a high of $26.4 million during Q2 2020, and its lowest value of $12,000 during Q2 2022.
  • In the last 3 years, Lifecore Biomedical's Capital Leases had a median value of $3.2 million in 2023 and averaged $2.1 million.
  • Per our database at Business Quant, Lifecore Biomedical's Capital Leases fell by 2.67% in 2020 and then surged by 26,683.33% in 2023.
  • Over the past 4 years, Lifecore Biomedical's Capital Leases (Quarterly) stood at $26.4 million in 2020, then reached $12,000 in 2022, then surged by 26,683.33% to $3.2 million in 2023, then climbed by 0.03% to $3.2 million in 2024.
  • Its Capital Leases stands at $3.2 million for Q2 2024, versus $3.2 million for Q2 2023 and $12,000 for Q2 2022.